- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Patent holdings for IPC class C07K 16/28
Total number of patents in this class: 41741
10-year publication summary
|
1848
|
2593
|
2989
|
3462
|
4144
|
4498
|
4806
|
4911
|
4372
|
1499
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 3650 |
815 |
| Genentech, Inc. | 3742 |
723 |
| F. Hoffmann-La Roche AG | 7958 |
565 |
| Immatics Biotechnologies GmbH | 1144 |
554 |
| Novartis AG | 11238 |
529 |
| Bristol-myers Squibb Company | 5080 |
524 |
| Amgen Inc. | 3779 |
503 |
| Hoffmann-La Roche Inc. | 3060 |
499 |
| The Regents of the University of California | 18943 |
456 |
| Memorial Sloan-Kettering Cancer Center | 1789 |
380 |
| Chugai Seiyaku Kabushiki Kaisha | 1259 |
344 |
| Janssen Biotech, Inc. | 1347 |
343 |
| The Trustees of the University of Pennsylvania | 4122 |
289 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
289 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
283 |
| Xencor, Inc. | 403 |
254 |
| Board of Regents, The University of Texas System | 5370 |
252 |
| Genmab A/S | 382 |
251 |
| Pfizer Inc. | 3322 |
244 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
239 |
| Other owners | 33405 |